CD13+CD133+ and CD13+CD90+ cells increase HCC tumor initiation and genotoxic chemoresistance to, e.g., doxorubicin (DXR) and fluorouracil (5′Fu) in parallel [150]. This evidence concerns the gene THY1 and hepatocellular carcinoma.